SCHEMBL26070656

SCHEMBL26070656

C/N=C\c1[nH]nnc1-c1cccc(Oc2ccc(F)cc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.38
▸ SCN4A P35499 1/20 0.36
▸ SCN9A Q15858 1/20 0.35
▸ MAPT P10636 4/20 0.34
▸ LMNA P02545 2/20 0.34
▸ CCNT1 O60563 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ TP53 P04637 2/20 0.34
▸ HAO1 Q9UJM8 2/20 0.34
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ P2RX3 P56373 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21945135 0.84 ADORA2A (0.42) MAPTLMNAALDH1A1CYP1A2CYP3A4
SCHEMBL21945114 0.82 MEN1 (0.39) MAPTLMNAHAO1MEN1ALDH1A1
SCHEMBL21945093 0.81 ADORA2A (0.41) SCN9AMAPTLMNAALDH1A1CYP1A2
SCHEMBL21945732 0.79 MAOA (0.38) SCN4AMAPTLMNAMAOBBTK
SCHEMBL21945192 0.78 MAPT (0.37) SCN9AMAPTLMNA
SCHEMBL21945763 0.77 DRD1 (0.40) SCN9AMAPTALDH1A1MGLL
SCHEMBL21945053 0.77 NMT1 (0.36) MAPTMAOBMEN1ALOX15NFKB1
SCHEMBL21945696 0.76 NPSR1 (0.35) SCN4ASCN9AMAPTLMNACYP1A2
SCHEMBL21945229 0.75 LTA4H (0.39) HAO1MAOBCYP2D6CYP2C9NPSR1
SCHEMBL26070235 0.75 HTR2A (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219477-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2023-08-02 — — EP disclosed
Send feedback